Amgen Launches Biomarker Assist™, a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing Read more about Amgen Launches Biomarker Assist™, a Program To Help More Patients With Non-Small Cell Lung Cancer Gain Access To Biomarker Testing
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics Read more about Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
Amgen to Acquire Rodeo Therapeutics Corporation Read more about Amgen to Acquire Rodeo Therapeutics Corporation
Amgen To Present At The Oppenheimer 31st Annual Healthcare Conference Read more about Amgen To Present At The Oppenheimer 31st Annual Healthcare Conference
Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash Read more about Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash
Amgen Announces 2021 Second Quarter Dividend Read more about Amgen Announces 2021 Second Quarter Dividend
BLINCYTO® (Blinatumomab) Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Read more about BLINCYTO® (Blinatumomab) Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia
Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma Read more about Tezepelumab Is The First Biologic To Significantly Reduce Exacerbations In Broad Population Of Patients With Severe, Uncontrolled Asthma
Amgen To Present At The Cowen 41st Annual Healthcare Conference Read more about Amgen To Present At The Cowen 41st Annual Healthcare Conference
Amgen To Webcast Investor Meeting At AAAAI Virtual Annual Meeting Read more about Amgen To Webcast Investor Meeting At AAAAI Virtual Annual Meeting
